Medical University of Graz
medunigraz.atTotal trials
460
Active
97
Phase 3
23
Total enrollment
9,252,365
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 10 of 10 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| L-ornithine L-aspartate | — | — | — | — | — | 1 | |
| Poractant alfa (Curosurf®) - 1-minute administration | — | — | — | — | — | 1 | |
| Poractant alfa (Curosurf®) - 5-minute administration | — | — | — | — | — | 1 | |
| Amoxicillin | — | — | — | — | — | 1 | |
| Cholecalciferol | — | — | — | — | 5 | ||
| Fecal microbiota transplantation | — | — | — | — | — | 1 | |
| Insect Venom | — | — | — | — | — | 2 | |
| Biomarker Monitoring | — | — | — | — | — | 1 | |
| all approved chemotherapeutic agents from second line | — | — | — | — | — | 1 | |
| Hepatect CP 50 I.E./ml infusion solution | — | — | — | — | — | 1 |
Next readouts
- 2024-07-23
- 2025-12
- 2025-12
- 2026-03
- 2026-03-01
- 2026-06
- 2027-03
- 2027-03
- 2028-07-01
Top conditions
- Pulmonary Hypertension16
- Type 1 Diabetes12
- Psoriasis9
- Type 2 Diabetes9
- Obesity9
- Liver Cirrhosis8
- Vitamin D Deficiency8
- Polymorphic Light Eruption6
Frequently asked questions about Medical University of Graz
- How many clinical trials does Medical University of Graz have on ClinicalTrials.gov?
- Medical University of Graz is listed as the lead sponsor on 460 clinical trials in ClinicalTrials.gov, 97 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Medical University of Graz's trials are in Phase 3?
- 23 of Medical University of Graz's trials are in Phase 3, spread across 10 active drug programs.
- What therapeutic areas does Medical University of Graz focus on?
- Medical University of Graz's most-studied conditions on ClinicalTrials.gov are Pulmonary Hypertension, Type 1 Diabetes, Psoriasis, Type 2 Diabetes, Obesity.
- When are Medical University of Graz's next clinical trial readouts?
- Medical University of Graz has 9 upcoming primary-completion readouts tracked here; the soonest is “Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome”, expected around 2024-07-23.